AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Precision Radiation Oncology Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Stereotactic radiotherapy: An educational narrative review

Agha Muhammad Hammad Khan1, Syed Furqan Ahmad Hashmi2, Benjamin Li3, Fatima Shaukat4, Yumna Ahmed4, Mahmoud Alfishawy5, Iqbal Al-Amri5, Rashid Bashir6, Furhan Altaf6, Sercan Yilmaz2, Jamsari Khalid2, Zahid Al Mandhari2, Nadeem Pervez2, Salim Chaib Rassou2, Layth Mula-Hussain7,8 ( )
Radiation Oncologist, Radiation Oncology Department, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
Radiation Oncologist, Radiation Oncology Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman
Radiation Oncologist, Radiation Oncology Department, University of Washington, Seattle, Washington, USA
Radiation Oncologist, CyberKnife and Tomotherapy Department, Jinnah Postgraduate Medical Center (JPMC), Karachi, Pakistan
Medical Physicist, Radiation Oncology Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman
Radiotherapy Technologist, Radiation Oncology Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman
Radiation Oncologist, Radiation Oncology Department, Dalhousie University, Halifax, Nova Scotia, Canada
Oncology Department, College of Medicine, Ninevah University, Mosul, Iraq
Show Author Information

Abstract

Stereotactic radiotherapy is a term collectively used to describe the radiation treatment techniques that allow for the delivery of highly precise ionizing radiation. It is usually a high dose per session in single or few fractions. This treatment approach has been in medical use for over six decades and has primarily evolved in the last two decades. Many patients benefit from this unique non-conventional radiotherapy approach. Its indications include various malignant, benign and functional problems in cranial and body sites. This technique is not widespread in developing countries compared to developed countries. This work is an educational narrative review for learners in radiation oncology. We aim to share the knowledge of this practice to improve precision radiation oncology globally. This review summarizes the basics of stereotactic radiotherapy, the technical prerequisites, the clinical considerations, the practical recommendations and the learning points from each site-specific region.

Keywords

Stereotactic radiotherapySRSSABRSRTSBRT

References

1

Barnett GH, Linskey ME, Adler JR, et al. Stereotactic radiosurgery—an organized neurosurgery-sanctioned definition. J Neurosurg. 2007;106(1):1–5.
Crossref Google Scholar
2

Lasak JM, Gorecki JP. The history of stereotactic radiosurgery and radiotherapy. Otolaryngol Clin North Am. 2009;42(4):593–599.
Crossref Google Scholar
3

Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol. 2007;30(6):637–644.
Crossref Google Scholar
4

Verma V, Mcmillan MT, Grover S, Simone CB. Stereotactic body radiation therapy and the influence of chemotherapy on overall survival for large (≥ 5 centimeter) non-small cell lung cancer. IJROBP. 2017;97(1):146–154.
Crossref Google Scholar
5

Foote M, Bailey M, Smith L, et al. Guidelines for safe practice of stereotactic body (ablative) radiation therapy. J Med Imaging Radiat Oncol. 2015;59(5):646–653.
Crossref Google Scholar
6

Lo SS, Slotman BJ, Lock M, et al. The development of stereotactic body radiotherapy in the past decade: a global perspective. Future Oncol. 2015;11(19):2721–2733.
Crossref Google Scholar
7

Pathak RS, Tibdewal A, Kinhikar R, et al. Practice Patterns and Perspectives on Stereotactic Body Radiation Therapy for the Metastatic Spine From Lower-and Middle-Income Countries. JCO Global Oncol. 2022;8:e2200167.
Crossref Google Scholar
8

Buckley L, Bacha B, Gaudet M, et al. Development of a Curriculum for the Implementation of Stereotactic Radiation Therapy Programs in Middle-Income Countries. JCO Global Oncol. 2022;8:e2100389.
Crossref Google Scholar
9

Mula-Hussain L, Wadi-Ramahi S, Li B, Ahmed S, de Moraes FY. Specialty portfolio in radiation oncology: a global certification roadmap for trainers and trainees (Handbook–Logbook). 2021; Qatar University Press.
10

Vapiwala N, Steinberg M, Gross C. The Accreditation Council for Graduate Medical Education's Recent Changes to Radiation Oncology Training Program Standards: Raising the Bar for Postgraduate Training Quality to Better Reflect Our Specialty and Better Serve Our Patients. Int J Radiat Oncol Biol Phys. 2023;115(2):285–287.
Crossref Google Scholar
11

Harrow S, Palma DA, Olson R, et al. Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes. IJROBP. 2022;114(4):611–616.
Crossref Google Scholar
12

Abel S, Lee S, Ludmir EB, Verma V. Principles and applications of stereotactic radiosurgery and stereotactic body radiation therapy. Hematol/Oncol Clin. 2019;33(6):977–987.
Crossref Google Scholar
13

Chetvertkov M, Monroe JI, Boparai J, et al. NRG oncology survey on practice and technology use in SRT and SBRT delivery. Front Oncol. 2020;10:602607.
Crossref Google Scholar
14

Song CW, Glatstein E, Marks LB, et al. Biological principles of stereotactic body radiation therapy (SBRT) and stereotactic radiation surgery (SRS): indirect cell death. IJROBP. 2021;110(1):21–34.
Crossref Google Scholar
15

Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res. 2012;177(3):311–327.
Crossref Google Scholar
16

Solberg TD, Balter JM, Benedict SH, et al. Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary. Pract Radiat Oncol. 2012;2(1):2–9.
Crossref Google Scholar
17

Huang B, Yang F, Yin M, Mo X, Zhong C. A review of multimodal medical image fusion techniques. Comput Math Methods Med. 2020; 2020.
Crossref Google Scholar
18

Bernstein D, Taylor A, Nill S, Oelfke U. New target volume delineation and PTV strategies to further personalise radiotherapy. Phys Med Biol. 2021;66(5):055024.
Crossref Google Scholar
19

Quiñones-Hinojosa A, McDermott MW. Angled screw holes for anterior posts and a frame-positioning device for gamma knife radiosurgery: allowing for better targeting of intracranial lesions. Neurosurgery. 2007;60(4):339–344.
Crossref Google Scholar
20

Bennion NR, Malouff T, Verma V, et al. A comparison of clinical and radiologic outcomes between frame-based and frameless stereotactic radiosurgery for brain metastases. Pract Radiat Oncol. 2016;6(6):e283-e290.
Crossref Google Scholar
21

Caillet V, Booth JT, Keall P. IGRT and motion management during lung SBRT delivery. Physica Med. 2017;44:113–122.
Crossref Google Scholar
22

Riou O, Llacer Moscardo C, Fenoglietto P, et al. SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques. Rep Pract Oncol Radiother. 2017;(2):103–110.
Crossref Google Scholar
23

Ma C-MC. Physics and Dosimetric Principles of SRS and SBRT. Mathews J Cancer Sci. 2019;4(2):1–16.
Crossref Google Scholar
24

Bentzen SM. Steepness of the radiation dose-response curve for dose-per-fraction escalation keeping the number of fractions fixed. Acta Oncol (Madr). 2005;44(8):825–828.
Crossref Google Scholar
25

Patel G, Mandal A, Choudhary S, Mishra R, Shende R. Plan evaluation indices: a journey of evolution. Rep Pract Oncol Radiother. 2020;25(3):336–344.
Crossref Google Scholar
26

Bezjak A, et al. Radiation Therapy Oncology Group RTOG 0813 seamless Phase Ⅰ/Ⅱ study of stereotactic lung radiotherapy (SBRT) For early stage, centrally located, non‑small cell lung cancer (NSCLC) in medically inoperable patients. Update. 2009.
Google Scholar
27

Freislederer P, Batista V, Öllers M, et al. ESTRO-ACROP guideline on surface guided radiation therapy. Radiother Oncol. 2022;173:188–196.
Crossref Google Scholar
28

Lewis BC, Snyder WJ, Kim S, Kim T. Monitoring frequency of intra-fraction patient motion using the ExacTrac system for LINAC-based SRS treatments. J Appl Clin Med Phys. 2018;19(3):58–63.
Crossref Google Scholar
29

Ho AK, Fu D, Cotrutz C, et al. A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Operative Neurosurg. 2007;60(suppl_2):ONS-147-ONS-156.
Crossref Google Scholar
30

Scher N, Bollet M, Bouilhol G, et al. Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking. Radiat Oncol. 2019;14(1):1–8.
Crossref Google Scholar
31

Yamazaki H, Ogita M, Himei K, et al. Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer. J Radiat Res (Tokyo). 2016;57(3):288–293.
Crossref Google Scholar
32

Lartigau EF, Tresch E, Thariat J, et al. Multi institutional phase Ⅱ study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. Radiother Oncol. 2013;109(2):281–285.
Crossref Google Scholar
33

Baliga S, Kabarriti R, Ohri N, et al. Stereotactic body radiotherapy for recurrent head and neck cancer: a critical review. Head Neck. 2017;39(3):595–601.
Crossref Google Scholar
34

Iqbal MS, West N, Richmond N, et al. A systematic review and practical considerations of stereotactic body radiotherapy in the treatment of head and neck cancer. Br J Radiol. 2021;94(1117):20200332.
Crossref Google Scholar
35

Combs SE, Baumert BG, Bendszus M, et al. ESTRO ACROP guideline for target volume delineation of skull base tumors. Radiother Oncol. 2021;156:80–94.
Crossref Google Scholar
36

Brunner TB, Haustermans K, Huguet F, et al. ESTRO ACROP guidelines for target volume definition in pancreatic cancer. Radiother Oncol. 2021;154:60–69.
Crossref Google Scholar
37

Sperduto W, Oyekunle T, Niedzwiecki D, et al. Toxicity and Dosimetric Parameters of Ablative Radiation Therapy in the Management of Patients with Child-Pugh B/C Liver Function and Unresectable Hepatocellular Carcinoma (HCC). Int J Radiat Oncol Biol Phys. 2021;111(3):e78.
Crossref Google Scholar
38

Hu Y, Zhao C, Ji R, et al. The role of stereotactic body radiotherapy in hepatocellular carcinoma: guidelines and evidences. J Natl Cancer Cent. 2022.
Crossref Google Scholar
39

Timmerman RD, Hu C, Michalski J, et al. Long-term results of RTOG 0236: a phase Ⅱ trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage Ⅰ non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014;90(1):S30.
Crossref Google Scholar
40

Shamp SJ, Sheikh S, Chang T, et al. Stereotactic body radiotherapy (SBRT) for T2N0 (>3 cm) non-small cell lung cancer: outcomes and failure patterns. J Radiosurg SBRT. 2021;7(4):271.
Google Scholar
41

Vasudevan HN, Raleigh DR, Johnson J, et al. Management of chordoma and chondrosarcoma with fractionated stereotactic radiotherapy. Front Sur. 2017;4:35.
Crossref Google Scholar
42

Baliga S, Matsui JK, Klamer B, et al. Clinical Outcomes and Efficacy of Stereotactic Body Radiation Therapy in Metastatic Pediatric Solid Tumors. Int J Radiat Oncol Biol Phys. 2021;111(3):e179-e180.
Crossref Google Scholar
43

Baliga S, Matsui J, Klamer B, et al. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. Br J Radiol. 2022;95(1133):20211088.
Crossref Google Scholar
44

Lee C-C, Yang H-C, Chen C-J, et al. Gamma Knife surgery for craniopharyngioma: report on a 20-year experience. J Neurosurg. 2014;121(Suppl_2):167–178.
Crossref Google Scholar
45

Napieralska A, Bekman B, Blamek S. Craniopharyngioma in Children and Adults–Does the Age Matter? Int J Radiat Oncol Biol Phys. 2022;114(3):e46-e47.
Crossref Google Scholar
46

Jackson WC, Silva J, Hartman HE, et al. Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies. IJROBP. 2019;104(4):778–789.
Crossref Google Scholar
47

Rühle A, Andratschke N, Siva S, Guckenberger M. Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma? Clin Transl Radiat Oncol. 2019;18:104–112.
Crossref Google Scholar
48

Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. IJROBP. 2000;47(2):291–298.
Crossref Google Scholar
49

Mahajan A, Ahmed S, Mcaleer MF, et al. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(8):1040–1048.
Crossref Google Scholar
50

Terakedis BE, Jensen RL, Boucher K, Shrieve DC. Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases. J Radiosurg SBRT. 2014;3(1):21.
Google Scholar
51

Soltys SG, Grimm J, Milano MT, et al. Stereotactic body radiation therapy for spinal metastases: tumor control probability analyses and recommended reporting standards. IJROBP. 2021;110(1):112–123.
Crossref Google Scholar
52

Soliman H, Ringash J, Jiang H, et al. Phase Ⅱ trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases. J Clin Oncol. 2013;31(31):3980–3986.
Crossref Google Scholar
53

Bydder S, Spry Na, Christie D, et al. A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases. Australas Radiol. 2003;47(3):284–288.
Crossref Google Scholar
54

Gutiérrez E, Sánchez I, Díaz O, et al. Current evidence for stereotactic body radiotherapy in lung metastases. Curr Oncol. 2021;28(4):2560–2578.
Crossref Google Scholar
55

Ilyas A, Chen C-J, Abecassis IJ, et al. Stereotactic Radiosurgery for A Randomized Trial of Unruptured Brain Arteriovenous Malformations-Eligible Patients: A Meta-Analysis. Neurosurgery. 2022;91(5):684–692.
Crossref Google Scholar
56

Ong V, Bourcier AJ, Florence TJ, et al. Stereotactic Radiosurgery for Glomus Jugulare Tumors: Systematic Review and Meta-Analysis. World Neurosurg. 2022.
Crossref Google Scholar
57

Sahyouni R, Mahboubi H, Moshtaghi O, et al. Radiosurgery of glomus tumors of temporal bone: a meta-analysis. Otol Neurotol. 2018;39(4):488–493.
Crossref Google Scholar
58

Kotecha R, Sahgal A, Rubens M, et al. Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion. Neuro-oncol. 2020;22(3):318–332.
Crossref Google Scholar
59

Pokhrel D, Sood S, Mcclinton C, et al. Linac-based stereotactic radiosurgery (SRS) in the treatment of refractory trigeminal neuralgia: detailed description of SRS procedure and reported clinical outcomes. J Appl Clin Med Phys. 2017;18(2):136–143.
Crossref Google Scholar
60

Narayanasamy G, Morrill S, Cousins D, et al. Radiosurgery for mesial temporal lobe epilepsy following ROSE trial guidelines—A planning comparison between Gamma Knife, Eclipse, and Brainlab. J Appl Clin Med Phys. 2019;20(10):134–141.
Crossref Google Scholar
61

Grimm J, Marks LB, Jackson A, Kavanagh BD, Xue J, Yorke E. High dose per fraction, hypofractionated treatment effects in the clinic (HyTEC): an overview. Int J Radiat Oncol Biol Phys. 2021;110(1):1–10.
Crossref Google Scholar
62

Moreno-Jiménez S, Álvarez-Guevara D, Moscardini-Martelli J, et al. A Survey on Prophylactic Corticosteroids Use in Stereotactic Radiosurgery Treatments From Ibero and Latin America Centers. Cureus. 2023;15(1):e34060.
Crossref Google Scholar
63

Sawlani V, Davies N, Patel M, et al. Evaluation of response to stereotactic radiosurgery in brain metastases using multiparametric magnetic resonance imaging and a review of the literature. Clin Oncol. 2019;31(1):41–49.
Crossref Google Scholar
Precision Radiation Oncology
Volume 8 Issue 1,
May 2024
Pages 47-58
DOI: 10.1002/pro6.1222
Cite this article:
Khan AMH, Hashmi SFA, Li B, et al. Stereotactic radiotherapy: An educational narrative review. Precision Radiation Oncology, 2024, 8(1): 47-58. https://doi.org/10.1002/pro6.1222

129

Views

0

Crossref

0

Scopus

Altmetrics
Received: 16 December 2023
Revised: 24 January 2024
Accepted: 17 February 2024
Published: 21 March 2024
© 2024 The Authors.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Return